Dr. Rob McMaster
B.C. researchers launching clinical trial for first genetically engineered stem cell-based therapy for type 1 diabetes
Researchers from the University of British Columbia and Vancouver Coastal Health (VCH) have received $1 million from Canada’s Stem Cell Network to conduct research and a clinical trial for one of the world’s first genetically engineered cell replacement therapies for type 1 diabetes.
May 12, 2022